SARS-CoV-2 infection during pregnancy is associated with a number of adverse pregnancy outcomes, including preeclampsia, preterm birth, and stillbirth, especially among pregnant women with severe COVID-19. Several fetal complications such as early pregnancy loss, delivery of a premature fetus, preeclampsia, fetal death, vertical transmission, intrauterine growth retardation, and congenital structural anomalies in association with COVID-19 disease have been investigated.Тo review on the fetal adverse outcome that is likely to occur during COVID-19 disease. The fetal detrimental outcomes that have been widely studied in the literature include preterm birth, stillbirth, vertical transmission. The evidence in the literature supports that there is a higher rate of preterm birth and stillbirth in women who tested positive for SARS-CoV-2 but their association with the disease is not completely clear. Furthermore, the emergence of other possible outcomes is not conclusively stated. Hence more studies are required to establish their association with COVID-19 disease to decrease and mitigate the risk of detrimental fetal outcomes through early interventions and preventive measures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.